Pages that link to "Q53701065"
Jump to navigation
Jump to search
The following pages link to Artemisinin-Resistant Plasmodium falciparum with High Survival Rates, Uganda, 2014-2016. (Q53701065):
Displaying 20 items.
- Molecular assays for antimalarial drug resistance surveillance: A target product profile (Q57154187) (← links)
- Artemisinin Resistance Outside of Southeast Asia (Q59809630) (← links)
- Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis (Q61446764) (← links)
- Investigation and Evaluation of Genetic Diversity of Kelch 13 Polymorphisms Imported From Southeast Asia and Africa in Southern China (Q64094431) (← links)
- K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors (Q64122400) (← links)
- Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda (Q64134489) (← links)
- Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan (Q89763562) (← links)
- Recovery and stable persistence of chloroquine sensitivity in Plasmodium falciparum parasites after its discontinued use in Northern Uganda (Q89763578) (← links)
- Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance (Q89881605) (← links)
- Effect of Drug Pressure on Promoting the Emergence of Antimalarial-Resistant Parasites among Pregnant Women in Ghana (Q90369653) (← links)
- No evidence of P. falciparum K13 artemisinin conferring mutations over a 24-year analysis in Coastal Kenya, but a near complete reversion to chloroquine wild type parasites (Q90572950) (← links)
- Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance (Q90672938) (← links)
- Decreased In Vitro Artemisinin Sensitivity of Plasmodium falciparum across India (Q92091334) (← links)
- Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties (Q92091610) (← links)
- The Diversity of the Plasmodium falciparum K13 Propeller Domain Did Not Increase after Implementation of Artemisinin-Based Combination Therapy in Uganda (Q92264490) (← links)
- Antimalarial drug resistance in Africa: the calm before the storm? (Q92375746) (← links)
- A brief history of artemisinin: Modes of action and mechanisms of resistance (Q92569274) (← links)
- Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018) (Q92787223) (← links)
- Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model (Q93222036) (← links)
- Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin: a systematic review (Q101127653) (← links)